Category Archives: Pharmaceuticals

Featured Stories

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it in the U.S., claiming they failed to warn about this ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Risperdal Litigation is Second Largest Mass Tort in Philadelphia

Risperdal Litigation is Second Largest Mass Tort in PA

Mass Tort Contains Risperdal Gynecomastia Lawsuits Lawsuits alleging the antipsychotic drug Risperdal caused gynecomastia continue to mount against Johnson & Johnson’s Janssen unit. In fact, Risperdal litigation accounts for most of the mass tort growth in Philadelphia’s Complex Litigation Center. … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Lawsuits Allege Abilify Caused Impulse-Control Problems

Lawsuits Allege Abilify Caused Impulse-Control Problems

Abilify Lawsuits Allege Gambling Addiction, Compulsive Behaviors Bristol-Myers Squibb and Otsuka Pharmaceuticals are facing lawsuits alleging that the antipsychotic medication Abilify caused impulse-control problems, including pathological gambling. Litigation continues to mount as cases are consolidated into a federal multidistrict litigation … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Serious Brain Side Effects of Dilantin

Epilepsy patients who take the drug Dilantin to control seizures could experience a variety of side effects, including atrophy of the cerebellum, an area of the brain important to the control of movement and coordination. Posture, balance, coordination and speech … Continue reading

Posted in Dilantin, Health Concerns, Pharmaceuticals |

Lawsuit Alleges Xarelto Led to Ischemic Stroke

Xarelto Lawsuits Continue to Mount Over Bleeding Injuries Bayer Healthcare AG, Johnson & Johnson, and Janssen Pharmaceuticals are facing a wrongful death lawsuit over allegations that their anticoagulant (blood thinner), Xarelto (rivaroxaban) led to a West Virginia man’s ischemic stroke … Continue reading

Posted in Pharmaceuticals |

Invega Linked to Serious Side Effects Such As Gynecomastia

Invega Linked to Serious Side Effects Such As Gynecomastia

Invega is a popular antipsychotic medication increasingly associated with serious side effects such as gynecomastia, or male breast growth. Invega, known also by its generic name, paliperidone, is manufactured and distributed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Propecia Litigation Moving Toward First Trial

The litigation involving serious and sometimes catastrophic side effects of the hair loss drug Propecia is moving forward, with the selection of bellwether cases. In such large litigations, representative cases—bellwether cases—are chosen to be the first to go to trial. … Continue reading

Posted in Defective Products, Health Concerns, Pharmaceuticals, Propecia, Proscar |

Depakote Anti-Epilepsy Medication Linked to Birth Defects

Depakote Anti-Epilepsy Medication Linked to Birth Defects

The family of a 12-year-old child has filed a lawsuit on behalf of the young girl who underwent an extremely difficult operation, along with her mother, while she was still in the womb. The highly complicated open fetal surgery took … Continue reading

Posted in Depakote, Pharmaceuticals | Tagged , , , , |

Estrogen Product Premarin Tablets Recalled due to Labeling Issues

Estrogen Product Premarin Recalled due to Labeling Issues

Pfizer, the maker of Premarin, announced a voluntary recall of one lot of 1.25mg tablets due to an incorrect expiration date on the bottle label. What is Premarin? Premarin is an estrogen product commonly used to treat moderate to severe … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

Controversial Diabetes Drug Actos Still on the Market

Controversial Diabetes Drug Actos Still on the Market

Though research has shown an association between the type 2 diabetes drug Actos and serious side effects including bladder cancer, heart failure, liver failure, and bone fractures, the Food and Drug Administration (FDA) has stopped short of recalling Actos. Actos … Continue reading

Posted in Actos, Pharmaceuticals | Tagged , , , , |

Clash Over Regulation of “Off-Label” Promotion of Drugs and Devices

Clash Over “Off-Label” Promotion of Drugs and Devices

A 2012 decision from the U.S. Court of Appeals for the Second Circuit that reversed the conviction of Alfred Caronia, a drug representative accused of conspiring to promote the drug Xyrem for unapproved uses set up a clash between the … Continue reading

Posted in Pharmaceuticals | Tagged , , , , |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.